Skip to main content

Table 3 The regimens of adjuvant chemotherapy

From: Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer

   Venous invasion  
  N Present Absent P-value
Regimen      
  S-1 41 23(24%) 18(19%) 0.346
S-1 plus cisplatin 14 10(10%) 4(4%) 0.086
5-FU plus methotrexate 12 4(4%) 8(8%) 0.200
UFT 12 5(5%) 7(7%) 0.511
S-1 plus paclitaxel 7 2(2%) 5(5%) 0.221
5-FU plus cisplatin 5 3(3%) 2(2%) 0.662
5-FU 5 1(1%) 4(4%) 0.148
Paclitaxel 1 1(1%) 0(0%) 0.241